Evidence map›Paper›PMID 38291844›Full record

ArticleMovement disorders clinical practice2024

Elderly Onset of Functional Motor Disorders: Clinical Correlates from the Italian Registry.

Christian Geroin, Martina Petracca, Sonia Di Tella, Enrico Marcuzzo, Roberto Erro, Sofia Cuoco, Roberto Ceravolo, Sonia Mazzucchi, Andrea Pilotto, Alessandro Padovani and 30 more

Abstract read
In one paragraph

Article in Movement disorders clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Treatment of Functional Neurological Disorders.Journal of clinical neurology (Seoul, Korea) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Christian GeroinNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.ORCID 0000-0001-6095-1930
Martina PetraccaMovement Disorder Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID 0000-0001-8033-3785
Sonia Di TellaDepartment of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy.ORCID 0000-0002-2248-5120
Enrico MarcuzzoNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Roberto ErroCenter for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry-Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.ORCID 0000-0002-7800-7419
Sofia CuocoCenter for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry-Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.
Roberto CeravoloCenter for NeuroDegenerative Diseases Parkinson and Movement Disorders, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.ORCID 0000-0003-1412-9406
Sonia MazzucchiCenter for NeuroDegenerative Diseases Parkinson and Movement Disorders, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Andrea PilottoNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.ORCID 0000-0003-2029-6606
Alessandro PadovaniNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Luigi Michele RomitoParkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.ORCID 0000-0002-6772-1035
Roberto EleopraParkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Mario ZappiaDepartment G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.ORCID 0000-0002-8298-9486
Alessandra NicolettiDepartment G.F. Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy.
Carlo DallocchioDepartment of Medical Area, Neurology Unit, ASST Pavia, Pavia, Italy.
Carla ArbasinoDepartment of Medical Area, Neurology Unit, ASST Pavia, Pavia, Italy.
Francesco BonoBotulinum Toxin Center, Neurology Unit A.O.U. Mater Domini, Catanzaro, Italy.
Vincenzo LaterzaBotulinum Toxin Center, Neurology Unit A.O.U. Mater Domini, Catanzaro, Italy.
Benedetta DemartiniAldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.
Orsola GambiniAldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Milan, Italy.
Nicola ModugnoIRCCS Neuromed, Pozzilli, Italy.
Enrica OlivolaIRCCS Neuromed, Pozzilli, Italy.
Laura BonanniDepartment of Medicine and Aging Sciences, University G. d'Annunzio, Chieti-Pescara, Italy.
Alberto AlbaneseDepartment of Neurology, IRCCS Humanitas Research Hospital, Rozzano, Italy.ORCID 0000-0002-5864-0006
Gina FerrazzanoDepartment of Human Neurosciences, Università La Sapienza, Rome, Italy.
Alessandro TessitoreDepartment of Advanced Medical and Surgery Sciences, University of Campania-Luigi Vanvitelli, Naples, Italy.
Leonardo LopianoDepartment of Neuroscience-Rita Levi Montalcini, University of Turin, Turin, Italy.
Giovanna Calandra-BuonauraDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Francesca MorganteNeurosciences Research Centre, Molecular and Clinical Sciences Neurosciences Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, United Kingdom.ORCID 0000-0002-9834-3639
Marcello EspositoClinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.
Antonio PisaniDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0002-8432-594X
Paolo ManganottiClinical Neurology Unit, Department of Medical, Surgical and Health Services, University of Trieste, Trieste, Italy.
Lucia TesolinFunctional Movement Disorders Outpt.Clinic, Clinical Neurology and Stroke Unit Dep., Central Country Hospital, Bolzano, Italy.
Francesco TeatiniFunctional Movement Disorders Outpt.Clinic, Clinical Neurology and Stroke Unit Dep., Central Country Hospital, Bolzano, Italy.
Serena CamozziNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Tommaso ErcoliDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Fabrizio StocchiUniversity and Institute of Research and Medical Care San Raffaele Roma, Rome, Italy.ORCID 0000-0002-5763-0033
Mario Coletti MojaOspedale degli Infermi, Department of Neurology, Ponderano, Italy.ORCID 0000-0002-8452-683X
Giovanni DefazioDepartment of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Michele TinazziNeurology Unit, Movement Disorders Division, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.ORCID 0000-0002-2370-7063

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFunctional motor disorders (FMD) are a frequent neurological condition affecting patients with movement disorders. Commonly described in younger adults, their manifestation can be also associated to an elderly onset.

objectiveTo assess the prevalence and describe the clinical manifestations of FMD with elderly and younger onset and their relationship with demographical and clinical variables.

methodsWe recruited patients with a "clinically definite" diagnosis of FMD from the Italian Registry of FMD. Patients underwent extensive clinical assessments. For elderly onset, we set a chronological cut-off at 65 years or older according to WHO definition. Multivariate regression models were implemented to estimate adjusted odds ratio of elderly FMD onset related to clinical characteristics.

resultsAmong the 410 patients, 34 (8.2%) experienced elderly-onset FMD, with a mean age at onset of 70.9 years. The most common phenotype was tremor (47.1%), followed by gait disorders, weakness, and dystonia (29.4%, 23.5%, 14.7%, respectively). Eleven elderly patients had a combined phenomenology: 9 exhibited two phenotypes, 2 had three phenotypes. Weakness was isolated in 3/8 patients and combined with another phenotype in 5/8, manifesting as paraplegia (n = 4); upper limb diplegia (n = 2), hemiparesis/hemiplegia (n = 1), and tetraparesis/tetraplegia (n= 1). Non-motor and other functional neurological disorders occurred more frequently in the younger group (89.1%) than the elderly (73.5%). Neurological and non-neurological comorbidities were more prevalent in the elderly group (82.4%) as opposed to the younger (32.7%). In a multivariate regression analysis, elderly-onset FMD was significantly associated with neurological comorbidities, including parkinsonism (OR 6.73) and cerebrovascular diseases (OR 5.48).

conclusionsThese results highlight the importance of achieving an accurate diagnosis of FMD in the elderly, as it is crucial for effectively managing FMD symptoms and addressing neurological comorbidities.

Indexed as

Motor DisordersMovement DisordersAdultAgedHumansItalyQuadriplegiaRegistriesTremorelderly onsetfunctional motor disordersfunctional neurological disordersfunctional parkinsonismneurological comorbidities

Identifiers

PMID38291844
PMCPMC10828615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.